64 results
8-K
EX-99.1
mld9wqvbqx
28 Mar 24
NeuroBo Pharmaceuticals Reports Year End 2023 Financial Results and Provides Corporate Update
8:01am
8-K
EX-99.1
n0od7z
18 Jan 24
Full Data Readout Expected in the Second Half of 2024
8:30am
8-K
pgh 2r4ami
18 Jan 24
Full Data Readout Expected in the Second Half of 2024
8:30am
8-K
EX-99.1
pic 80mmr59kp
13 Nov 23
NeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:14pm
8-K
EX-99.1
6v74ur10
15 Sep 23
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of NASH
8:11am
8-K
EX-10.1
awfst9747bqw
29 Jun 23
Submission of Matters to a Vote of Security Holders
8:36am
8-K
EX-99.1
gxhp k9jds
30 Mar 23
NeuroBo Pharmaceuticals Reports Full Year 2022 Financial Results
4:47pm
8-K
EX-10.1
mbgcvg6
22 Dec 22
Departure of Directors or Certain Officers
5:08pm
8-K
EX-10.2
nhdvldhvvih40686
22 Dec 22
Departure of Directors or Certain Officers
5:08pm